- Galera Therapeutics ( NASDAQ: GRTX ) was trading ~16% down after the biopharmaceutical company said it is set to sell 14.32M shares and warrants to purchase up to 14.32M shares in an ~$30M registered direct offering.
- The offering involves a price of $2.095 per share and accompanying warrant. The warrants have an exercise price of $1.97 per share.
- Galera will sell all the shares in the offering.
- The offering is expected to close on or about Feb. 17.
- Source: Press Release
For further details see:
Galera Therapeutics down after announcing ~$30M registered direct offering